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FOR THE TPAT STUDY GROUP? 
artery pteney were exsmintd in 108 patients who took part 
a prwiwsly rcpartcd piace~ontrolled trial of recombinant 
tiwtelype plasmlnqw~ activator Irt.PA) in wte myocnrdial 
inlnrctlm. Cwmary angiograpky was performed I? f 0.8 h atlrr 
inidatkn oftreatment In 47 patients @ramup A) or at 10 day* in 61 
ptknts fgroup Bj. Both #oups underwent radiinuclide rmtric- 
ulagnpby 3.8 t 0.8 b and ~gntn on day 9 atIer treatment and 
qluntitstivo tkalthun uinttgrapby en day 8. 
la grwp A, tk bdarct-related artery WE patent in 53%: these 
pIttaB bnd a sm8ll.r global (15.1 * LSB YS. 23.7 * 4.1%. p = 
0.08) and regtansl ILL7 * 2.5% ,I. 21.1 * 4.1%. p = O&u) 
tied ,haIh,m defect thsn did those with an occluded artery. 
lnfuct regt%nal ejectian iractlon improvwl by 10.1 2 2.1% 
Thrombolytic therapy reducer the mortality raw in acu,e 
myocardial infarction il-31. Because morMi,y reducdon has 
been achieved witho”, improvemen, in left ~entr~ular func- 
tion (4.5). as well as by the late (Iha, i\. 6 ,o ?4 h afler 
symptom onrel) ;Idminis,ra,ion of thrombolytic lhrrapy (2). 
the question arises ar !n whethsr rhe benefirs of this therapy 
stem solely from early coronary :brumbolysis and rerulling 
myofardiai salvage. A wealth of informawn altea lo Ihe 
efficacy of lhrombolytic thetapy in prcservinp I?,7 venlricu- 
brtwen earlv and late studies nken Ike infarct~related artw HIS 
lar function m acu,e m)ocardial infarction. An incre%inp 
body of evidence @-I11 confirms lha, such benefits arc 
medmled rhrough early coronary patency. However dircc, 
evidence relating prewwation of left ventncular funclion to 
sn mdependen, measure of infarct size reduclion is more 
limilcd. I, therefore seems approptiate to reevaluate the 
$uficancc of infarct-rela,ed coronary vessel patency in 
xu,e myocardial infarcbon 8s assessed both early and 
ln,e af,cr thromboly,,c lhenpy. wi,h panicular reference 
,o Ihe !mpkcationc for inhrct size and ven,ricular funclion 
(I?). 
We previously reporled t 131 a placebo-con,rolled trial of 
rhrombolyhc therapy in acute myowdlal infarclion in which 
early ,reatmcn, with recombma% fiwx-fype plasminogcn 
activator WPA) rcsulled in improved global and regional 
MI vcn,r~ular function when measured during in-hospital 
convill~~cencc. In rhc present report. we examine Ihe rek- 
lion\ among angiographically dewrmmed coronary pa,ency. 
myocxdial infarc, size measured by quanlitative thallium 
sciotigraphy and glob:! and regional eft ventricular function 
measured by radiunuclidc venrriculography in the fame 
group of pa!~cn,s. Our pro!ocol prwded a oniqne opponu- 
nity to evaluate the impact of spontaneous coronary throm- 
b&is on thess same mcasureb in a placebo-treated cohort. 
The principal hgpothesi5 evaluated in this study w&s that 
early establishment of coronary artery patency after acute 
myocardial infarction leads to limitation of infarct size and 
improved left ventricular function. Additional objectives 
were to determine whether I) coronary artery patency 
measured at the time of hospital discharge is associated with 
reduced Infarct size and improved left ventricular funcuon: 
and ?I a quantitative relation exists between infarct size and 
left ventricular function. 
Methods 
Study patients. The recruitment ofpatients and the inves- 
tigative protocol have been reported elsewhere (131. Patients 
(20 10 75 years of age) with typical ischemic chest pain of 
230 min in duration and ST segment elevation on the 
electrocardiogram (ECGJ of 20. I mV in two inferior leads or 
leads I and aVL. or z&IS mV in two or more anterior 
precordial leads were recruited from IO participaling hospi- 
tals. Patients with prior myocardial infarction were excluded 
only if they were known to have preexisting Q waves in the 
zone of the acute current of injury on the ECG. Patients 
were also excluded if they presented S3.75 h after the onset 
of symptoms or had cardiogenic shock. left bundle branch 
block. prior aortocomnary bypass surgery. recent coronary 
angioplasty (cl month) or standard contraindications to 
thrombolytic therapy. Recruitment in this study was termi- 
nated before achievement of the planned sample size of 303 
patients bv the eeneral release of R-PA for clinical ournoses. 
Rsodo~ieati& and treannent. Patients were ~anbomly 
allocated to treatment with either double chain n-PA lBur- 
roughs Wellcomc Co.1 or matching placebo as previously 
described. The first 39 patients enrolled received n-PA in a 
dose of 0.4 MU/kg body weight for the 1st h. ItX as a bolur 
injection, followed by an infusion of0.14 MU/kg per h during 
the 2nd h and 0.03 MU/kg per h for the final 8 h. The 
remaining 19 patients received n-PA in a dose of 0.4 MU/kg 
over the Is, h. 0.08 MU/kg per h over the next 2 h and 
0.03 MU/kg per h for the remaining 4 h. This change in the 
infusion duration was made in light of independent studies 
with this agent (Burroughs Wellcome Co.. unpublished 
observations). indicating that longer infusion times may 
increase hemorrhaeic risk without orovidinr B oatencv ad- 
vantage. All pat&s received heparin as a b&s d&e of 
4,OCnl IU intravenouslv immediatelv before administration of 
r&PA or placebo ani thereafter by a continuous infusion 
for% h to maintain the partial thromboplastin time between 
1.5 and 2 times the control value. Enteric-coated aspirin 
(325 mglday oral!y) was begun on dny 3 to overlrp with 
hewin therapy. 
Coronary &togrophy. Coronary angiography was per- 
formed according 16 a predetermined protocol. The timing of 
angiography defined two groups: grocp A consisted of 
patients initially admitted to the three institutions with the 
capacity for coronary angiography. Group A patients under 
went coronary angiography I7 ? 0.8 h after initiation of 
study treatment to document early patency of the infarct- 
related coronary vessel. Those group A patients with i lwlc 
occIusil)n of the infarct-related vessel underwent repeat 
catheteriz&m on day IO to document reocclusion: how- 
ever. for the purpose of this analysis. only the re~ttlts of the 
initial study are included. 
Group B consisted of patients initially admitted to insti- 
tutions without facilities for cardiac catheterization: these 
patients were transferred by random assignment to one of 
the three angiographic institutions on hospital day 4 and 
underwent coronary angiogrdphy on hospital day- IO. All 
coronary cngiograms were independently reviewed without 
knowledge of patient data at a core w&graphic site for 
infarct-related vessel patency according to the criteria of the 
Thmmbolysis in Myocardial Infarction (TIMI) trial invesri- 
gators 114). The infarct-related vcsset was considered to be 
occluded if assessed as having TIM1 perfusion grade 0 or I 
and to be patent if assessed as having TIM1 perfusion grade 
2 or 3. 
Radionuclldt vtntrkulography. Radionuelide left vetttric- 
ulography was performed 3.8 ? 0.8 h (early) after the 
initiation of treatment and again on hospital day 9 (late). A 
standard protocol was used in all Darticivtttine institutions. 
After in v/tro labeling of red blood ceils whh t&hnetium-49m 
I30 mCi). studies were acsuired in anterior and 45” and 70” 
left anterior oblique views&g the multigaled acquisition of 
32 frames/cardiac cycle. All studies were transferred to the 
core nuclear laboratory. using suitable translation software 
when necessary. One tech&gist who had no knowledge of 
clinical data performed all analyses. Global left ventricular 
ejection fraction was determined by using a semiautomated 
method for definition of end-diastole and end-tvstole. with 
background calculated from a left paraventric&r region of 
interest. Regional ejection fraction was calculated in the 45’ 
left anterior blique view for one inferoapical, two septal and 
two posterolateral segments. each encompassing 60” of the 
circumference of the left ventricle (the base excluded). 
Assignment of segments for calculation of the infarct re- 
gional ejection fraction was keyed to the qualifying ECG: for 
anterior infarction, the one inferoapical and two xptal 
segments were averaged. whereas for inferior infarction the 
one inferoapical and two postemlateral segments were aver- 
aged. 
Quantitative thnlllum rintigraph~. Single pboton emis- 
sion computed tomographic thallium i;.?lging was performed 
on hospital day 8 with use of a uniform protocol. At peak 
symptom-limited treadmill exercise testing (Bruce protocol). 
thallium-201 (3 mCi: was injected intravenously and the 
patient exercised for I min. Imaging was begun 5 mitt after 
exercise with the patient supine. An anterior planar image 
was acquired. followed by continuous acquisition beginning 
in the 45” light anterior oblique projection, moving clockwise 
around the heart to 135” left anterior obbque. with storage in 
a 64 X 64 matrix at 3” intervals. Images obtained 4 h after 
exercise wzre Gmilarly acquired. All data were transferred 
to the core nuclear laboratory. where the rballium tomo- 
grams were reconstructed and displayed in a “bulfs-eye” or 
polar format. A defect was defined a\ aclwity occurring 
2.5 SD below the limits defined m 17 normal subjects. 
Defects were localized to either anterior or inferior ~axular 
territories and their Gze was expressed as n percent of rhe 
total bull’s-eye. The proportion of the initial defect that was 
fixed was determined by comparian of the strew and 4 b 
studies. Global thallium defect was defined as the total fixed 
defect expressed as a percent of the whole left ventricle and 
thus might include defects both within and renwte from the 
infarct zone. Regional thallium defect war defined as the 
fixed defect occurring only wkhin the infarct zone (deter- 
mined from the qualifying ECG). again expressed as il 
percent of the total left ventricle. 
Crealinc klnave (CK)-MB isaenzyme determination. Sam- 
ples for serum CK MB isoenryme dmemdnations were 
drawn at 4 h intervals for the 1st 36 h and at I? b intervals 
thereafter throughout the remaining hospital course. The CK 
MB activity was determined in IUiliter using i>oimmune CK 
(Roche). Reinfarction war defined BE a secondary increase in 
CK MB of r5W over the previous value when CK MB had 
not previously returned to normal. 
Dalaanatysis. Continuous variables are reported as mea 
values t SC. Single comparisons of mean v&es were made 
by Student’s t test with one or tw taili. depending on the 
presence or absence of a predetermined directional hypoth- 
esis. Categoric variables were compared by chi-square anal- 
ysis. The purpose of this repat is to describe the impact of 
either early or late coronary vewl patency on subsequent 
measures of infarct size and left ventricular function. Ac- 
cordingly. within each group. the results are analyzed by 
Patency of the infarct-related vessel. Analysis of variance 
was used to test for a potential effect of treatment assign- 
ment over and above patency alone. Differences betwen 
groups were considered significant at a p value rO.05. 
Linear regresriott analysis wa!, performed to quantify the 
relation between left ventricular func!ion and infarct size. 
The protocol and consent form were approved by the 
Human Subjects Review Committee of the University of 
Toronto and the Institutional Review Boards of the partici. 
paling hospitals. All patients provided written infomed 
consent. 
Results 
One hundred fifteen patients were randomized. 56 10 
placebo and 59 to n-PA. Forty-nme patients were admitted 
to the three hospitals with the capability of performing 
corona,~ angiography. One patient did not undergo early 
coronary angiography because of hemodynamlc instability. 
Sixty-six patitnts were admitted IO the remaining institu- 
tions. Of these. four did not undergo late coronary angiog- 
raphy (two died. two had rcfu\edl. Two other patients. one 
from each group. were excluded from this analyxs because 
their coronary angiogmms were nor available for interpreta- 
tun m the cwr laborator,. The total study grow therefore 
con&cd of lOi3 patientb..Four patients in-g&p.A and two 
pauents in group B underwnt a revascuiarizarion procedure 
before performance of the day 9 radionuclide ventriculo- 
gram. 
Baseline clinkal characteristic% (Tabk I). Group A pa- 
Gents with an occluded infarct-related vessel tended to be 
older tp = 0.07) than those with a patent vessel. The extem 
of coronary artery disease (~50% diameter stenosis of a 
maior eptcardial coronary anew or its branches) was similar 
in both &oups A and E and their subgroups. 
Coronary artery ps‘ecy. Gwp A. At 17 2 0.8 h after 
symptom onset. the infarct-r&cd artery was patent in 15 of 
47 parients (7 of 24 placebo-treated and I8 of 23 rt-PA- 
treated. p = 0.001). 
Group 8. In those patients undergoing catheterization 
only at day IO. the infarct-related vessel was patent in 41 of 
61 ,I7 of 29 placebo-treated and 24 of 32 rt-PA-tresed. p = 
O.IS). 
Thallium scintigmphy. Group A (Tnhle 2A): Fixed global 
and regional thallium defects were significantly smaller in 
patients with a patent ar opoosed to an occluded infarct- 
related ve%el at early cathe:rrization. 
Gmup B ITable 2BJ: Patients with a patent iniarct-related 
vessel at late catheteriration demonrtrard a tendency. lp = 
NSI toward smalter mean giohal and regional fixed thallium 
defe:! sizes than those of patients with an occluded vessei. 
Radionuckde ventriculognp8y. Grwp A ITable 2AJ. Pa- 
tency of the infarct vessel at early coronary angiography was 
sssocnted with 2 trend toward improved mean day 9 global 
and infarct region left ventricular ejection fracrion. Mean 
day 9 noninfarct region ejection fraclion~ did not differ by 
patency. All summary mesawe, of left wntricular function 
improved significantly betwell the early and day 9 studies 
Ip < O.W8 for global ejection fraction and p < O.OOOI for 
each infarct and noninfarct region ejection fractionl. The 
impmvemenr in mean infarct region ejection fraction was 
rigndiclntlygrealer in patients ha&gapatcnt ralherthan ao 
occluded infarct-related vessel (Fig. I): tPz change overtime 
in either global or noninfarct region function was similar 
irrespecwe of infarct-related versel patency. The preseence 
Figure 1. Bar graph of the absolule changer occwrmg in global. 
inlarcl region and noninfarcl region left ventricular ejection fraaion 
IA EF %I between radionuclide ventriculogr~ms performed on day I 
and day 9 tbr group A padems (coronary al tery patency determined 
II I8 h after inidadon of wenmen~. cla5rihcd hy periuiion status of 
the infarct-relaed coronary ~nery (TIMI perfwion grade 0 to 31. 
Histograms represent mew value\ and error bx,. i SEM: p wlues 
are forcomparisonr(lao.lalled,ofIhc m;lgnitudc ofimprovement in 
ejecuon fraction between patients havmg occluded (TIMI p&ion 
grade 0 or I) vcrsu~ patent lTlMl perfuuon grade ! or 3) infarct- 
related anerier. 
19 GROUPA P=oo48 T 
or absence of +.CO% stenosis in the coronary vessels sub- 
serving the noninfarcl territory did not influence either mean 
noninfarct region ejection fraction on day 9 (p = 0.56) or the 
change from early to Iale eslimadons (p = 0.67). 
Grwp B Vfuhk 28). Mean global. infarct region and 
noninfxcc region ejection fraclion values on day 9 were 
rimdar. irrespeclive of infarct-related vessel patency deler- 
mmed id late calhewizaion. The mean changes between 
early and late eslimateb for patients with a patent vcr~us an 
occluded infarct-related vessel were. respectively. global 
ejecdon fraction 0.4 + 2.4% versus 4.8 ? 1.5% (two-tailed 
p = 0.131. infarct region ejection fraction 3.5 + 2% versus 
4 I 1.8% Itwo-failed p = 0.87) and noninfarct regionejection 
fraclion 3.1 C 2.2% verws2.9 ? Z.S%(Iwo-laii;,. p = 0.93). 
lnteraelian of infarctwrlsted vessel pakney. thallium de- 
Feet size and regional kfl ventricular function. There was a 
strong linear inverse relation between a fixed thallium defect 
and infarct region ejection fraction among group $ patients 
with an initially occluded infarct-related vessel (r = -0.83. 
p C O.OODI) IFig. 2). A much waker relation was found 
among group A palients with an initially patent inbrct- 
related vessel (r = -0.17. p = 0.46). The difference in 
correlalion coefficienls is hiehlv sicnifican; Cz = 2.90. D = 
0.004). Exclusion from Ihe”a&& of Ihe IO groui A 
patients experiencing one or more of the following- 
angiographically documented reocclusion of the infarct- 
related vessel (n = 4). dacumenled reinfaction (n = 31 or 
mechanical revascularizarion before performance of the day 
9 ndionuclide wgiogram 01 = 4)-did ilot significanlly alter 
the observed difference m correlalion between lhose with 
and wilhoul a patent infarct-related vessel. After adjustm:m 
for baseline charwarislicr. including infarct loadon. trerd- 
nent assignment. history of previous myocardial infarction. 
gender, age and time ID treatment in a multiple linear 
regression mod&. fixed regional thalliumdefect remained as 
:he mosl imponanl determinant of infarct regional function 
in those with an occluded infarct-r&led vessel bu* had no 
statistically significant influence m thwe with a psten; w- 
sel. 
In prorrp B. there WBF a st&licaIlp Ggoificant relahon of 
intermediate strength between regional tiullium defect and 
infarct regional ejection fraction irrespectne of the la 
patency status of the infwccrelaled vessel lr = -0.71, p = 
0.001 occluded and r = -0.71. p < O.wOI patent,. 
lnflwnee of treatment assignment. In view of the oh- 
sewed influence of treatment %signment on infarct-relaled 
vessel patency in group A. the ndionuclide angiographic and 
thallium scinlipraphic resuks were cumined for an effect of 
trerdmem with n-PA beyond that uue to mfwcl-related 
vessel patency alone. In neither group A nor group B wa, 
there evidence for an imeraction of ve~\eI palency and 
treatment assignment with either lefi ventricular function or 
infarct size. 
CK MB. In group A. the mean lime 10 peak CK MB wa\ 
10.9 ? 0.8 h when the infarct-related ve,rel was patent and 
14.9 2 I h when it was occluded (p < O.o1)5l. In group B. the 
meantimelopeakCK-MB wab 12.5 r U.Saod 13.4 I I.? h 
for those with and without a patent infarct-related vewl. 
respectively. a difference that was not statis&lly Gpifi- 
cant. Mean peak CK MB did not differ by infarct-relaled 
vessel patency in either group A or group B. 
Discussion 
Farly infarct-related v ssel patency. The prmcipal finding 
of this study is that early coronary artery patency rewltb in 
buth a reduction in ;rfarct siLe and an improvement in 
regional left ventricular function. lnprovemenl in left ven- 
tncular funclion was related lo direct and indirecl evidence 
of early infarct-related versel patency in previw report\ 
(6-11.15). hut lhevr studiet were limited hv the o% of 
enzymatic estimates of infarct siLe. Ritchle et 01. f 161. uing 
radionuclide techniques. demonstrated a reduction in infarct 
size and improved Ief! vmtnculnr funcdon in paienls with 
acute myocardial infarctton receiving iowavenous streptoki- 
nave in a placebo-rumrolled trial. hut coronary artery pa- 
tency war not documented. Barsand et al. c 171 demonstraled 
greater coronary artery patency. Ggmfiiandy improved left 
ventricular function and ‘A reducLlon in infarcl size among 
pstieas recewing rhromholytic therapy for a first acute 
m!ocardial mfarclion. A drec, relation between vessel 
pa,ency. infarct size and ventricular function was impSed 
hut not \pecilically addressed. The presem study provides 
the mo\t complete description 10 date of lhe impondnce of 
early mfarcr-related bezel oseocy in infact size and left 
venn2dsr function. 
Yiuninfarct region funetian. We were unable lo demon- 
\traLc h~perkio&iaofthc nomnfarct zone ming radionuclide 
vcntriculography. Early hywrkinesia of the noninfarct zone 
has been dercribed ,7.18.1% when left venuicular function 
uu it>,cwzd by contrast angiography. hut the frequency 
with which this phenomenon is observed has varied. We 
were i&o unable to delcct an effect of eilha infarct-related 
vessel patency (18) or conlmlateral coronary artery disease 
on nomnfilrct Rgioo function. The rew,o for the discrep 
aocy between this and previous studies is unclear. II may he 
argued that radianuclide ventriculogmphy is ler? suitable 
than contrast angiognphy for the measuremenl, of regional 
left ventricular function. However. we have previously 
reported t 13) lhal vislial wall motion analysis closely paml- 
leh the lindmgs of semiautomated radionuclide left venrric- 
ulogrephy. 
WC ;d~o demonstrated that function improves in hcxh 
infarct and noninfarct regions over time and that a simple 
reciprocal relation between Ihe two regions does not emerge 
as an wtifact of the method. This suggests that the radionu- 
elide ventrudognphic techmques employed in rhis study 
provide Q meaningful description of dynamic changes in left 
venuicular function after acute myocardial infarction. 
Late infarebrelstcd vessel patency. In contrast to the 
favorable implications of early patency. the ~tatos of the 
infarct-related vessel at day IO showed weaker associations 
with i&rct size and left ventricular function. This is con- 
cordant with the results of Kennedy et al. (41. who demon- 
strated a survival advantage of 8 late open infarct-related 
vessel unrelated to preservation of left ventricular function. 
Although spontaneous coronary thromholysis is well de- 
scribed (20). it IS probable tha: much of this reopening ocwS 
after a time when myocardial salvage can be realized. 
Evidence that this is the case is afforded by the enzyme data 
in our group B patients. whose lime to peak CK MB was 
similar whether or not there was late infarct-related vessel 
patency. Thus, classification by late vessel patency alone 
describes patient groupr heterogeneous with respect toacute 
coronary anery patency. Whereas late infarct-related vessel 
patency~ may &nuat~ infarct expansion during the early 
convakscem period after myocardial infarction (21). the 
ultimate effects on left ventricular function and manality 
may be delayed and therefore not detectable during the 
in.haspital phase. The current study cannot address these 
latter issues, but does suggest that the mechanisms of 
clinical benefit beyond limitation of infarct size deserve 
further investigetion. 
Relation of infarct size and regional fundion. There is 
conflicting evidence as to whether ventricular function and 
infarct size are linearly related t 16.17.22-24). This study 
provides insight into this controversy by demonstrating that 
the relation between regional infarct size and ventricular 
function is importantly influenced by the early patency 
status of the infarct-relax-d artery. In patients with an 
initially closed vessel. there was a strong linear inverse 
relation between resional infarct size and ventricular func- 
tion at hospital discharge. In such patients. it is likely that 
the vessel occluded at I7 5 0.8 h had been persistently 
occluded and that a large component of the myocardium at 
risk was irreversibly damaged. This relation did not exist in 
patients whose infarct-related vessel was patent early, even 
though we documented a Subsequent improvement in re. 
gional left ventricular function. Because the thallium and 
radionuclide ventriculographic studier were acquired wilhin 
24 h of one another, it is unlikelv that intercurrent clinical 
events could have influenced their relation. 
The sharply ditTering relations observed between regional 
function and infarct size. dependent on infarct-related vessel 
patency, could not be accounted for by baseline inequalities 
of the group A subgroups or by exclusion from analysis of 
those patients experiencing reinfarftion. revarculariration 
or reocclusion. Persistent myocardial stunning may have 
been operative in patients experiencing early reperfusion. 
thereby contributing to a lack of association between infarct 
size and venlricular function, but our own data suggest that 
the influence of stunning was limited (13). The potential 
difficulties in the esumation of infarct size by thallium 
scinrigraphy. particularly in the setting of thromholytic ther- 
apy (251, could also account for the<e differences. but it is of 
interest to note that the infarct size estimates from quanti- 
tative thallium rcintigraphy reported in this study are similar 
in magnitude to those reported by others (16.171 using 
similar techniquer. The fai!ure to demonstrate a similarly 
dichotomous relation (by late vessel patency) in group B 
palients is attnbutable to the limited relevance of late vessel 
patency to early events. 
Treatment assignment. In this Study. there was no mter- 
action between treatment assignment and infarct-related 
vessel patency with regard to mcaswes of infarct size and 
ventricular function. This observation is consistent with the 
biologically plausible hypothesis that early coronary artery 
patency is equally beneficial. whether acquired spontane- 
ously or by meam of pharmacologically induced thrombol- 
ysis. 
Limitations. The principal limitation of this study relates 
to the relatively small number of subiects within each ofthe 
post-hoc subgroups. This is peninenito interpretation of the 
lack of cffcct of late infarct-related vessel patency in group 
B, in vhich the power to detect differences in infarct size and 
left ventricular function of the magnitude demonstrated is 
4.5. Thus. the conclusions are necessarily guarded because 
of this limited statistical pwxr. 
Conclusion. This study provides evidence that the estab- 
lishment of early coronary artery patency is a necessary 
requirement for reducing infarct size and improving regional 
left ventricular function. Late infarct-related vessel patency 
was not associated with similar salutary effects, suggesting 
that mortality benefits in such patients are not mediated 
through myocardial salvage. Early spontaneous restoration 
of coronary flow may be associated with benefits similar to 
those achieved by pharmacologic thrombolysis. Although 
the relation between infarct size and ventricular function is 
complex in patients with early infarct-related vessel patency. 
this did not impair our ability to detect an improvement in 
regional fuoction during hospital convalescence. Future 
thrombolytic strategies should continue to emphasize 
achieving and maintaining the highest rates of e&We 
corooa~y artery pateocy in the early hours after the onset of 
symptoms of a& my&rdial i&tion. Further investiga- 
tion into the mechanisms whereby late vessel patency me- 
diates clinical benefit is required. 
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